Millennium Laboratories Announces New Chief Operating Officer David Cohen

Millennium Laboratories Announces New Chief Operating Officer David Cohen
 
 
Download image SAN DIEGO, Aug. 30 /PRNewswire/ -- Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain, announced today the appointment of David Cohen to Chief Operating Officer. In his capacity as COO, Mr. Cohen is responsible for new business analysis and development to expand the Company's core business. He also has oversight of Millennium's legislative initiatives and community outreach programs.

(Photo: http://photos.prnewswire.com/prnh/20100830/LA56535)

(Photo: http://www.newscom.com/cgi-bin/prnh/20100830/LA56535)

"David's track record of success in negotiation fund raising, SEC compliance and investor relations brings tremendous value to Millennium," said James Slattery, Chief Executive Officer. "His experience has already contributed greatly to our expansive growth and enhanced our reputation in the pain management arena."

"It's an honor to take on this new challenge at Millennium and to build on the momentum created by our new marketing, sales and operational initiatives," stated Cohen. "Our customer focus and emphasis on groundbreaking research position us to take Millennium to the next level."

David Cohen originally joined Millennium Laboratories as Chief Analytics Officer. In his 28-year career, Mr. Cohen has served as a public company Chief Financial Officer, Controller and later Executive Vice president of a $500 million dollar real estate conglomerate operating in 38 states and the commonwealth of Guam. He has also been involved with several start-ups and turnaround situations. His reputation as a skilled negotiator is well-earned - he has raised more than $35 million for specific projects in private and public offerings.

He has a Bachelor of Science degree in both Economics and Accounting. A Certified Public Accountant, Mr. Cohen has twice been licensed by the National Association of Securities Dealers (NASD) as a Financial Operations Principal.

About Millennium Laboratories

Millennium Laboratories, Inc. is a national, research-based medication monitoring company whose test panels, technology, customer support, educational resources and experts are specifically focused on clinicians who treat chronic pain.  The company has the only major Urine Drug Testing (UDT) laboratory exclusively utilizing the latest cutting-edge technology, Liquid Chromatography/Mass Spectrometry/Mass Spectrometry (LC-MS/MS). This allows Millennium to provide the fastest turn-around time in the industry for determining the presence and precise levels of drugs in a patient's urine, usually in one business day.

Located in San Diego's life sciences cluster, Millennium offers pain management practitioners industry-leading test accuracy in conjunction with clinical decision support through its RADAR Hotline 12 hours every business day.  Millennium is the only reference laboratory certified as a training facility for toxicology scientists and operates as a unique research component of the University of California, San Diego's (UCSD) doctoral program in Pharmacy. Millennium serves as an industry, government and payer educator and a compassionate advocate for chronic pain sufferers throughout the United States. The company is accredited by The Joint Commission, receiving the Gold Seal of ApprovalTM for healthcare quality and safety.  For more information, visit the Millennium Laboratories website, www.becausepainmatters.com.


SOURCE Millennium Laboratories, Inc.

Suggested Articles

CureVac will spend the bulk of the proceeds on its COVID-19 vaccine, with the rest going to manufacturing, platform development and other programs.

WuXi names Dong to helm new vaccines CDMO; Paragon appoints Jimenez as capital makers lead; Levy joins Spark as CMO.

The phase 1 and 2 results suggest the vaccine may be safe, tolerable and capable of triggering production of antibodies against the coronavirus.